Variants in the GNPTAB gene are associated with Mucolipidosis type II or type III alpha/beta (MIM# 252500 and 252600, respectively), clinical entities that are biochemically characterized by an increase of lysosomal hydrolases activity in the blood patients and present remarkable phenotypic features [40]. Here, GNPTAB is linked to mucolipidosis type II.